However,
Hcls file their first implant:
Since the start of the summer, the Civil Hospices in Lyon have been offering a new alternative for people with sleep apnea. Similarly, A first implant was filed this July 18 at the Croix-Rousse hospital.
4 to 5 % of the French population suffers from obstructive sleep apnea: a night ventilation disorder characterized by. Meanwhile, the frequent occurrence of apnea of breathing during sleep. Similarly, Until then. Therefore, two treatments were given to patients with this pathology: continuous positive pressure ventilation (PPC) or the mandibular advance orthosis, two sometimes ineffective treatments or intolerated by patients.
But since the summer, the Civil Hospices in Lyon have been offering an alternative to these treatments: “Inspire” technology. For example, Based on a neurostimulation device. However, this solution makes it possible to maintain the open respiratory tract, to regain a quality of sleep hcls file their first implant without mask or orthosis and thus reduce the risks linked to this pathology.
A technology of which Jean-Michel, a 59-year-old patient, will be the first to take advantage of. Operate this Friday. July 18 at the Croix-Rousse hospital, the fifties hopes to gain in quality of life: “The orthosis had not worked at all and the machine, it is very difficult to live on a daily basis. Of course, we are talking about an implant and it is not trivial but I am young and healthy. Beyond the efficiency of the device, it is the gain in life that matters to me today”, Share the patient.
How does it work? – Hcls file their first implant
“Inspire technology works thanks to a neurostimulator implanted at the level of the hyperglosse nerve. which controls the muscles of the tongue. Connected to a probe placed in the rib cage. this device works like a pacemaker: hcls file their first implant when a respiratory break is detected during sleep, the neurostimulator sends an electric impulse that will advance the tongue, thus facilitating air inlet”explains the HCL. This stimulation mechanism is synchronized with the patient’s natural breathing. Each evening, the latter can easily activate the device using a simple remote control.
To be eligible for this solution. patients must display a BMI below 32, and lend themselves to an endoscopic examination under general anesthesia, to check their compatibility with the device. Once operated, the patient must wait three months, the healing time, to activate the device.
With this technology, HCL becomes the twelfth French center to offer this technology already well established in several other countries.
Read also: Lyon: Pierre Luzeau succeeds Bruno Lacroix as president of the HCL Foundation
Further reading: Only one person in the world has this blood group, and is French – Prescribing a sporting activity to adolescents would improve their mental health, and they need it! – Chikungunya: 12 Aboriginal transmission homes identified in mainland France | The doctor’s daily life | Specialties – 12 transmission foci and thirty cases of contamination reported in France – A high level meeting was held in Cotonou ` – The new forum.